Tag: Drug manufacturing

Browse exclusive Tags!

Nephron Pharmaceuticals Faces Continued Issues with Sterile Drug Production, FDA Inspection Reveals, US

Nephron Pharmaceuticals faces FDA scrutiny and ongoing recalls over sterile drug production, highlighting the need for improvements.

NPPA Expands Price Control to 23 More Drugs

India's National Pharmaceutical Pricing Authority has extended price control regulations to include 23 more drugs for illnesses such as arthritis, tuberculosis and diabetes. Manufacturers must now review their pricing to ensure patients are not being overcharged. This move aims to make drugs more affordable for patients, with ceiling prices set for essential treatments. Manufacturers must also provide regulators with a full list of prices via the IPDMS, and display a price list at their business site for easy access.

Popular

Nephron Pharmaceuticals Faces Continued Issues with Sterile Drug Production, FDA Inspection Reveals, US

Nephron Pharmaceuticals faces FDA scrutiny and ongoing recalls over sterile drug production, highlighting the need for improvements.

Subscribe

spot_imgspot_img